Forced degradation studies of rapamycin: Identification of autoxidation products

The immunosuppressant drug rapamycin, also known as Sirolimus, underwent autoxidation under mild conditions to give numerous monomeric and oligomeric compounds, which were generally characterized by size-exclusion chromatography and NP-HPLC with UV and MS detection. Some of the more predominant prod...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmaceutical and biomedical analysis Vol. 59; pp. 194 - 200
Main Authors Oyler, Alan R., Segmuller, Brigitte E., Sun, Yanqiu, Polshyna, Ann, Dunphy, Richard, Armstrong, Barbara L., Achord, Patrick, Maryanoff, Cynthia A., Alquier, Lori, Il’ichev, Yuri V.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 05.02.2012
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The immunosuppressant drug rapamycin, also known as Sirolimus, underwent autoxidation under mild conditions to give numerous monomeric and oligomeric compounds, which were generally characterized by size-exclusion chromatography and NP-HPLC with UV and MS detection. Some of the more predominant products, epoxides and ketones, were isolated and identified. Two epoxides and 10 S-epimer of rapamycin were described for the first time. Observed rapamycin isomers were also addressed. Computational chemistry was used to provide mechanistic insights. Formation of the majority of the rapamycin products could be rationalized with free radical-mediated autoxidation reactions involving alkene and alcohol sites. Methodological aspects of oxidative stress testing are discussed.
Bibliography:http://dx.doi.org/10.1016/j.jpba.2011.10.017
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0731-7085
1873-264X
DOI:10.1016/j.jpba.2011.10.017